Skip to main content
lexblog.com/lib/3MKG6BZPviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Increased Scrutiny of Drug Pricing – What Should Pharmaceutical Companies Know",
    "url": "https://www.lexblog.com/2016/02/24/4-2/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-3MKG6BZP",
        "url": "https://www.lexblog.com/lib/3MKG6BZP/"
    },
    "datePublished": "2016-02-24T11:00:00-05:00",
    "dateModified": "2018-07-26T10:21:48-04:00",
    "author": {
        "@type": "Person",
        "name": "Lee H. Rosebush, Nita Garg, Lindsay Holmes"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Baker & Hostetler LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Law Update",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "http://www.healthlawupdate.com/?p=3509",
    "sourceStability": "may-move"
}